NASDAQ$BTTC

Black Titan Corp · Q3 2016 earnings

Q3 2016 earnings · Reported Nov 9, 2016 (10 years ago) · Investor relations

Nov 9Sep 30, 2016

Total Revenue

$26K

No prior period

EPS (adj)

-$432.00

Previous: -$11.41-3685.7%

Capital Expenditures

$48K

Previous: $47K+2.1%

Free Cash Flow

$8.65M

No prior period

Net Income

-$2.62M

Previous: -$1.81M-45.0%

Operating Income

-$2.62M

Previous: -$1.8M-45.2%

Gross Profit

-$1.56M

No prior period

Cash & Equivalents

$16.5M

Previous: $9.69M+70.2%

Total Assets

$23.5M

Previous: $14.9M+57.9%

Stock-Based Comp

$202K

Previous: $92K+119.6%

Titan Pharmaceuticals · Revenue · Quarterly

$26K

Q3 2016

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation